MassMutual Private Wealth & Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.27M | Sell |
20,135
-288
| -1% | -$56.5K | 0.11% | 146 |
|
|
2026
Q1 | $4M | Sell |
20,423
-237
| -1% | -$46K | 0.11% | 144 |
|
|
2025
Q4 | $3.59M | Sell |
20,660
-235
| -1% | -$42.8K | 0.09% | 151 |
|
|
2025
Q3 | $3.98M | Sell |
20,895
-858
| -4% | -$152K | 0.1% | 152 |
|
|
2025
Q2 | $3.91M | Sell |
21,753
-352
| -2% | -$61.1K | 0.1% | 150 |
|
|
2025
Q1 | $3.74M | Sell |
22,105
-205
| -0.9% | -$33.7K | 0.11% | 149 |
|
|
2024
Q4 | $3.37M | Sell |
22,310
-200
| -0.9% | -$31.1K | 0.09% | 154 |
|
|
2024
Q3 | $3.49M | Sell |
22,510
-77
| -0.3% | -$11.5K | 0.1% | 165 |
|
|
2024
Q2 | $3.09M | Sell |
22,587
-202
| -0.9% | -$27.7K | 0.09% | 166 |
|
|
2024
Q1 | $3.03M | Buy |
22,789
+6,166
| +37% | +$800K | 0.09% | 168 |
|
|
2023
Q4 | $2.29M | Buy |
16,623
+184
| +1% | +$24.2K | 0.08% | 181 |
|
|
2023
Q3 | $2M | Buy |
16,439
+218
| +1% | +$29K | 0.07% | 187 |
|
|
2023
Q2 | $2.28M | Buy |
16,221
+534
| +3% | +$73.6K | 0.08% | 182 |
|
|
2023
Q1 | $2.22M | Buy |
15,687
+164
| +1% | +$23.5K | 0.08% | 179 |
|
|
2022
Q4 | $2.43M | Buy |
15,523
+386
| +3% | +$55.5K | 0.1% | 169 |
|
|
2022
Q3 | $1.86M | Buy |
15,137
+892
| +6% | +$117K | 0.08% | 182 |
|
|
2022
Q2 | $1.89M | Buy |
14,245
+1,403
| +11% | +$191K | 0.08% | 178 |
|
|
2022
Q1 | $1.76M | Buy |
12,842
+2,381
| +23% | +$332K | 0.07% | 200 |
|
|
2021
Q4 | $1.81M | Buy |
10,461
+909
| +10% | +$138K | 0.07% | 194 |
|
|
2021
Q3 | $1.39M | Buy |
9,552
+269
| +3% | +$39.4K | 0.06% | 205 |
|
|
2021
Q2 | $1.23M | Buy |
9,283
+906
| +11% | +$119K | 0.05% | 214 |
|
|
2021
Q1 | $1.07M | Buy |
8,377
+2,049
| +32% | +$252K | 0.05% | 216 |
|
|
2020
Q4 | $754K | Buy |
6,328
+2,068
| +49% | +$252K | 0.04% | 234 |
|
|
2020
Q3 | $488K | Buy |
4,260
+791
| +23% | +$93.5K | 0.03% | 266 |
|
|
2020
Q2 | $395K | Buy |
3,469
+3,344
| +2,675% | +$355K | 0.03% | 272 |
|
|
2020
Q1 | $10K | Hold |
125
| – | – | ﹤0.01% | 518 |
|
|
2019
Q4 | $13K | Hold |
125
| – | – | ﹤0.01% | 579 |
|
|
2019
Q3 | $13K | Sell |
125
-37
| -23% | -$3.8K | ﹤0.01% | 555 |
|
|
2019
Q2 | $16K | Hold |
162
| – | – | ﹤0.01% | 523 |
|
|
2019
Q1 | $14.6K | Hold |
162
| – | – | ﹤0.01% | 546 |
|
|
2018
Q4 | $13.5K | Sell |
162
-17
| -9% | -$1.59K | ﹤0.01% | 529 |
|
|
2018
Q3 | $19.3K | Hold |
179
| – | – | ﹤0.01% | 509 |
|
|
2018
Q2 | $19.7K | Hold |
179
| – | – | ﹤0.01% | 501 |
|
|
2018
Q1 | $18K | Sell |
179
-100
| -36% | -$10.2K | ﹤0.01% | 518 |
|
|
2017
Q4 | $27.5K | Buy |
279
+117
| +72% | +$11.1K | ﹤0.01% | 501 |
|
|
2017
Q3 | $15.2K | Hold |
162
| – | – | ﹤0.01% | 689 |
|
|
2017
Q2 | $18K | Buy |
+162
| New | +$17.1K | ﹤0.01% | 637 |
|
|
2015
Q4 | – | Sell |
-20
| Closed | -$1.21K | – | 845 |
|
|
2015
Q3 | $1.21K | Buy |
+20
| New | +$1.4K | ﹤0.01% | 730 |
|
|
2014
Q4 | – | Sell |
-20
| Closed | -$1.21K | – | 634 |
|
|
2014
Q3 | $1.21K | Buy |
+20
| New | +$1.23K | ﹤0.01% | 705 |
|
Other funds holding DGX
AIM
ECSS
EB
CPC
AIM
AAMU
AAIS
MassMutual Private Wealth & Trust's DGX Position: Q2 2026 in Review
MassMutual Private Wealth & Trust reduced its Quest Diagnostics (DGX) stake by 1.4% in Q2 2026, selling an estimated $56.5K and leaving 20,135 shares worth $4.27M. The position accounts for 0.11% of the portfolio, ranked #146.
MassMutual Private Wealth & Trust first reported a position in DGX in Q3 2014 and has held it in 39 quarters since. 444 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- MassMutual Private Wealth & Trust held 20,135 shares of Quest Diagnostics worth $4.27M as of Q2 2026.
- MassMutual Private Wealth & Trust sold 288 Quest Diagnostics shares in Q2 2026, an estimated $56.5K.
- Quest Diagnostics made up 0.11% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #146 holding.
- MassMutual Private Wealth & Trust first reported a position in Quest Diagnostics in Q3 2014 and has held it in 39 quarters since.
- 444 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.